Correlation Between Esperion Therapeutics and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and Organogenesis Holdings, you can compare the effects of market volatilities on Esperion Therapeutics and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Organogenesis Holdings.
Diversification Opportunities for Esperion Therapeutics and Organogenesis Holdings
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Esperion and Organogenesis is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and Organogenesis Holdings
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 3.34 times less return on investment than Organogenesis Holdings. In addition to that, Esperion Therapeutics is 1.14 times more volatile than Organogenesis Holdings. It trades about 0.01 of its total potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.04 per unit of volatility. If you would invest 262.00 in Organogenesis Holdings on September 2, 2024 and sell it today you would earn a total of 125.00 from holding Organogenesis Holdings or generate 47.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. Organogenesis Holdings
Performance |
| Timeline |
| Esperion Therapeutics |
| Organogenesis Holdings |
Esperion Therapeutics and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and Organogenesis Holdings
The main advantage of trading using opposite Esperion Therapeutics and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |